Bridge Medicines appoints William J. Polvino as Chief Executive Officer
Monday, March 27, 2017 - 09:02
in Health & Medicine
As Chief Executive Officer of the newly formed drug discovery company, founded by Rockefeller University and its two neighboring institutions, Polvino will be responsible for building a portfolio of early-stage drug discovery projects and advancing each program from animal proof of principle to clinical trials. More »